US BANCORP \DE\ - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2024$47
-96.6%
13
-96.9%
0.00%
Q1 2024$1,363
+4443.3%
413
+3076.9%
0.00%
Q4 2023$30
+76.5%
130.0%0.00%
Q3 2023$170.0%130.0%0.00%
Q2 2023$17
+88.9%
130.0%0.00%
Q1 2023$9
-10.0%
130.0%0.00%
Q4 2022$10130.0%0.00%
Q3 2022$0130.0%0.00%
Q2 2022$0130.0%0.00%
Q1 2022$0130.0%0.00%
Q4 2021$0130.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 2,435,806$1,721,8710.88%
Monaco Asset Management SAM 1,316,245$930,4540.28%
DAFNA Capital Management LLC 1,096,513$775,1250.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$5,205,9210.22%
Clearline Capital LP 2,052,709$1,451,0600.22%
Rubric Capital Management LP 10,366,120$7,327,8100.19%
Orbimed Advisors 7,747,891$5,476,9840.11%
Rock Springs Capital Management LP 6,244,897$4,414,5180.10%
683 Capital Management, LLC 2,000,000$1,413,8010.10%
Privium Fund Management (UK) Ltd 177,200$131,1280.10%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders